Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Treatment optimization in early triple negative breast cancer.
Expert Rev Anticancer Ther. 2023 Jul-Dec;23(10):1107-1116. doi: 10.1080/14737140.2023.2268840. Epub 2023 Oct 26.
Expert Rev Anticancer Ther. 2023.
PMID: 37873652
Review.
Biomarkers for Antibody-Drug Conjugates in Solid Tumors.
Katrini J, Boldrini L, Santoro C, Valenza C, Trapani D, Curigliano G.
Katrini J, et al. Among authors: santoro c.
Mol Cancer Ther. 2024 Apr 2;23(4):436-446. doi: 10.1158/1535-7163.MCT-23-0482.
Mol Cancer Ther. 2024.
PMID: 38363729
Review.
Item in Clipboard
Tumor Infiltrating Lymphocytes across Breast Cancer Subtypes: Current Issues for Biomarker Assessment.
Valenza C, Taurelli Salimbeni B, Santoro C, Trapani D, Antonarelli G, Curigliano G.
Valenza C, et al. Among authors: santoro c.
Cancers (Basel). 2023 Jan 26;15(3):767. doi: 10.3390/cancers15030767.
Cancers (Basel). 2023.
PMID: 36765724
Free PMC article.
Review.
Item in Clipboard
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center.
Valenza C, De Pas TM, Gaeta A, Castellano G, Santoro C, Corona A, Chiappini G, Vivanet G, Trapani D, Coppola S, Conforti F, Mattar D, Gandini S, Veronesi P, Pennacchioli E, Curigliano G.
Valenza C, et al. Among authors: santoro c.
Eur J Cancer. 2024 Jan;196:113423. doi: 10.1016/j.ejca.2023.113423. Epub 2023 Nov 10.
Eur J Cancer. 2024.
PMID: 37977104
Item in Clipboard
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
Attili I, Valenza C, Santoro C, Antonarelli G, Trillo Aliaga P, Del Signore E, Catania C, Spitaleri G, Passaro A, de Marinis F.
Attili I, et al. Among authors: santoro c.
Front Oncol. 2022 Aug 10;12:980765. doi: 10.3389/fonc.2022.980765. eCollection 2022.
Front Oncol. 2022.
PMID: 36033444
Free PMC article.
Item in Clipboard
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Boscolo Bielo L, Belli C, Crimini E, Repetto M, Ascione L, Pellizzari G, Santoro C, Fuorivia V, Barberis M, Fusco N, Rocco EG, Curigliano G.
Boscolo Bielo L, et al. Among authors: santoro c.
Oncologist. 2024 Mar 23:oyae038. doi: 10.1093/oncolo/oyae038. Online ahead of print.
Oncologist. 2024.
PMID: 38520742
Free article.
Item in Clipboard
Cite
Cite